Evidence map›Paper›PMID 33069383›Full record

ReviewAnnales de cardiologie et d'angeiologie2020

[SARS-COV-2 myocarditis. An update].

D Fard, R Huguet, A Koutsoukis, C Deguillard, A-S Tuffreau, J-F Deux, P Lim, E Teiger

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annales de cardiologie et d'angeiologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

D FardInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France. Electronic address: damien.fard@aphp.fr.
R HuguetInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
A KoutsoukisInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
C DeguillardInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
A-S TuffreauInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
J-F DeuxInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service d'imagerie médicale, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
P LimInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
E TeigerInserm U955, Institut Mondor de recherche biomédicale, université Paris-Est Créteil, 94010 Créteil, France; Service de cardiologie, hôpital universitaire Henri-Mondor, AP-HP, 94010 Créteil, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the SARS-CoV-2 virus responsible for the COVID-19 disease has given rise to a new disease whose boundaries are still to be discovered. While the first data suggested a purely respiratory infection, the most recent publications highlight a large pleomorphism of the disease, responsible for multiple organ damage, of which cardiac injury seems to be the most represented. This cardiac injury can present as acute myocarditis. Our aim was to discuss the pathophysiological rationale underlying the existence of SARS-CoV-2 myocarditis and to analyze the literature data regarding the diagnosis and treatment of this particular entity.

Indexed as

COVID-19HumansMyocarditisAtteinte cardiaqueCardiac injuryCoronavirusCOVID-19MyocarditeMyocarditisSARS-CoV-2

Identifiers

PMID33069383
PMCPMC7543970
OpenAlexW3091996871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.